Pharma Globenewswire

Heparin-induced Thrombocytopenia Market Analysis, Epidemiology Forecast, and Treatment Landscape Through 2032

8 April 2026

DelveInsight’s comprehensive analysis titled “Heparin-induced Thrombocytopenia Market Insights, Epidemiology, and Market Forecast-2032” offers detailed intelligence on Heparin-induced Thrombocytopenia, encompassing historical and projected epidemiological data alongside Heparin-induced Thrombocytopenia market dynamics across the United States, EU5 nations (Germany, Spain, Italy, France, and United Kingdom),

Uncategorised

Congenital Adrenal Hyperplasia Drugs Market 2034: Emerging Therapies, Clinical Trials, and Key Players

8 April 2026

(Albany, USA) – DelveInsight’s “Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive analysis of the CAH landscape, covering current treatment practices, emerging therapies, market share of individual drugs, and projected market size from 2020 to 2034

Uncategorised

Alopecia Areata Market: Emerging Therapies, Epidemiology, and Growth Forecast 2026–2036 Across Seven Major Markets

7 April 2026

Alopecia Areata Market The alopecia areata market is poised for steady growth, with a strong compound annual growth rate (CAGR) projected from 2026 to 2036. This expansion across the 7MM will be driven by the launch of innovative therapies, including RINVOQ (upadacitinib),

Uncategorised

SGLT2 Inhibitor Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

7 April 2026

DelveInsight’s “SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the SGLT2 Inhibitor, historical and Competitive Landscape as well as the SGLT2 Inhibitors market trends in the United States, EU4 (Germany, France,

Uncategorised

CLK Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

7 April 2026

DelveInsight’s “CLK Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the CLK Inhibitor, historical and Competitive Landscape as well as the CLK Inhibitors market trends in the United States, EU4 (Germany, France,

Uncategorised

Hepatic Cirrhosis: Comprehensive Market Intelligence, Epidemiology, and Forecast Analysis Through 2032

7 April 2026

DelveInsight’s “Hepatic Cirrhosis Market Insights, Epidemiology, and Market Forecast-2032” analysis provides comprehensive understanding of Hepatic Cirrhosis, encompassing historical and projected epidemiology alongside market trajectories across the United States, EU5 nations (Germany, Spain, Italy, France, and United Kingdom), and Japan. Download analysis @https://www.delveinsight.com/report-store/hepatic-cirrhosis-market?utm_source=pngw&utm_medium=pr&utm_campaign=kkpr

Uncategorised

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

6 April 2026

Acute Kidney Injury Market, DelveInsight Acute Kidney Injury therapies such as RBT-1, OCE-205, and other emerging candidates are anticipated to contribute significantly to the expansion of the Acute Kidney Injury Market in the coming years. DelveInsight has released a new report titled

Uncategorised

Spondylolisthesis Market Poised for Significant Growth Driven by Advanced Spinal Therapies, Rising Disease Burden, and Expanding Surgical Innovation Across Seven Major Countries

6 April 2026

Spondylolisthesis Market Summary The Spondylolisthesis market is undergoing a significant transformation as heightened awareness, evolving clinical protocols, and next-generation spinal technologies converge to address a condition that affects millions worldwide. DelveInsight’s latest market analysis reveals that the spondylolisthesis treatment landscape is expanding

Uncategorised

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

1 April 2026

Celiac disease represents a growing global health concern, with current management limited to lifelong adherence to a gluten-free diet—an approach often associated with compliance challenges and reduced quality of life. The increasing prevalence of diagnosed cases and significant unmet clinical needs are

Latest

Heparin-induced Thrombocytopenia Market Analysis, Epidemiology Forecast, and Treatment Landscape Through 2032

Congenital Adrenal Hyperplasia Drugs Market 2034: Emerging Therapies, Clinical Trials, and Key Players

Alopecia Areata Market: Emerging Therapies, Epidemiology, and Growth Forecast 2026–2036 Across Seven Major Markets

SGLT2 Inhibitor Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

CLK Inhibitors Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

Hepatic Cirrhosis: Comprehensive Market Intelligence, Epidemiology, and Forecast Analysis Through 2032

Acute Kidney Injury Market: Epidemiology, Therapies, Companies, DelveInsight

Spondylolisthesis Market Poised for Significant Growth Driven by Advanced Spinal Therapies, Rising Disease Burden, and Expanding Surgical Innovation Across Seven Major Countries

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Recent Posts

Banner

Newsletter

Authors